Cargando…

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common cancer and third most common cause of cancer-associated mortality worldwide. Hepatectomy and liver transplantation are the main treatments for early HCC. Immunotherapy and targeted therapy for advanced HCC have become increasingly popular; howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Yang, Gang, Li, Qiang, Xie, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751345/ https://www.ncbi.nlm.nih.gov/pubmed/33376525 http://dx.doi.org/10.3892/ol.2020.12353

Ejemplares similares

TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma
por: Tian, Feng, et al.
Publicado: (2017)

Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
por: Wang, He, et al.
Publicado: (2021)

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
por: Dong, Xiaogang, et al.
Publicado: (2017)

Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis
por: Yu, Tao, et al.
Publicado: (2020)

Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
por: Tang, Qin, et al.
Publicado: (2022)

Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma
por: Song, Chunrong, et al.
Publicado: (2019)

Fibrillarin antibodies in systemic sclerosis
por: Lee, Adrian
Publicado: (2021)

Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma
por: Feng, Hao, et al.
Publicado: (2019)

High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2017)

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Linjun, et al.
Publicado: (2022)

Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma
por: Cheng, Qianqian, et al.
Publicado: (2023)

Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma
por: Xiong, Dan‐dan, et al.
Publicado: (2022)

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2014)

High-level SETD1B gene expression is associated with unfavorable prognosis in hepatocellular carcinoma
por: Chen, Dong, et al.
Publicado: (2019)

Bioinformatic Analysis and In Vitro and In Vivo Experiments Reveal That Fibrillarin Participates in the Promotion of Lung Metastasis in Hepatocellular Carcinoma
por: Luo, Weixin, et al.
Publicado: (2022)

Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Sha, Meng, et al.
Publicado: (2021)

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
por: Guo, Xufeng, et al.
Publicado: (2021)

Current research on viral proteins that interact with fibrillarin
por: Decle-Carrasco, Stefano, et al.
Publicado: (2023)

Fibrillarin evolution through the Tree of Life: Comparative genomics and microsynteny network analyses provide new insights into the evolutionary history of Fibrillarin
por: Pereira-Santana, Alejandro, et al.
Publicado: (2020)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
por: Zhang, Chris Zhiyi, et al.
Publicado: (2012)

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
por: Wang, Qiao, et al.
Publicado: (2018)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma
por: Dong, Zhanfei, et al.
Publicado: (2022)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma
por: Gerber, Tiemo Sven, et al.
Publicado: (2023)

Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
por: Ji, Zaixiong, et al.
Publicado: (2021)

Fibrillarin-GFP Facilitates the Identification of Meiotic Competent Oocytes
por: Wang, Ting, et al.
Publicado: (2021)

High MCM8 expression correlates with unfavorable prognosis and induces immune cell infiltration in hepatocellular carcinoma
por: Yu, Meng, et al.
Publicado: (2022)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast
Publicado: (1991)

NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer
por: Li, Yunlong, et al.
Publicado: (2015)

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2018)

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2012)

High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)

Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma
por: Cao, Xiangang, et al.
Publicado: (2020)

Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma: Strobe-Compliant Article
por: Chen, Ruohua, et al.
Publicado: (2015)

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6oc1msbs6bdr30m8n1r1idu30q